Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Cancer Immunology, Immunotherapy : CII|May 5, 2007
Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivoCor H J Lamers, Sabine C L Langeveld, Corrien M Groot-van Ruijven, et al.
Scientific Reports|October 12, 2019
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigensBas Weenink, Kaspar Draaisma, Han Z Ooi, et al.
Journal of Leukocyte Biology|October 18, 2024
MerTK signaling in human primary T cells modulates memory potential and improves recall responseAnne Rahbech, Annina Kurzay, Sara Fresnillo Saló, et al.
Thrombosis and Haemostasis|July 1, 2010
mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cellsMichiel H Strijbos, Brigitte A van Krimpen, Reno Debets, et al.
NPJ Breast Cancer|May 12, 2026
Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventionsNadine S van den Ende, Marcel Smid, John W M Martens, et al.
Cancer Research|June 21, 2018
Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 ExpressionKimberley Kolijn, Esther I Verhoef, Marcel Smid, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypesYarne Klaver, Maud Rijnders, Astrid Oostvogels, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancerNadine S van den Ende, Marcel Smid, John W M Martens, et al.
European Journal of Immunology|April 7, 2011
T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapyJános Roszik, Zsolt Sebestyén, Coen Govers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2016
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell ResponsesAndre Kunert, Mandy van Brakel, Sabine van Steenbergen-Langeveld, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|May 5, 2007
Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivoCor H J Lamers, Sabine C L Langeveld, Corrien M Groot-van Ruijven, et al.
Scientific Reports|October 12, 2019
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigensBas Weenink, Kaspar Draaisma, Han Z Ooi, et al.
Journal of Leukocyte Biology|October 18, 2024
MerTK signaling in human primary T cells modulates memory potential and improves recall responseAnne Rahbech, Annina Kurzay, Sara Fresnillo Saló, et al.
Thrombosis and Haemostasis|July 1, 2010
mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cellsMichiel H Strijbos, Brigitte A van Krimpen, Reno Debets, et al.
NPJ Breast Cancer|May 12, 2026
Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventionsNadine S van den Ende, Marcel Smid, John W M Martens, et al.
Cancer Research|June 21, 2018
Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 ExpressionKimberley Kolijn, Esther I Verhoef, Marcel Smid, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypesYarne Klaver, Maud Rijnders, Astrid Oostvogels, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancerNadine S van den Ende, Marcel Smid, John W M Martens, et al.
European Journal of Immunology|April 7, 2011
T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapyJános Roszik, Zsolt Sebestyén, Coen Govers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2016
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell ResponsesAndre Kunert, Mandy van Brakel, Sabine van Steenbergen-Langeveld, et al.
Pageof 14